Opening book details…
About this Medicine article
The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide by Rapkins, R. W.; Wang, F.; Nguyen, H. N.; Cloughesy, T. F.; Lai, A.; Ha, W.; Nowak, A. K.; Hitchins, M. P.; McDonald, K. L. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Rapkins, R. W.; Wang, F.; Nguyen, H. N.; Cloughesy, T. F.; Lai, A.; Ha, W.; Nowak, A. K.; Hitchins, M. P.; McDonald, K. L.
- Publisher
- Duke University Press; Oxford University Press; Oxford University Press (OUP) (ISSN 1522-8517)
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)